Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Infographics: Hepatitis C Filter by - Any -BlogCampaignEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefThe issuesTopic overviewVideo Letter | 09 August 2021 Hepatitis C Open letter to AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C Photograph by Aleksandr Glyadyelov Feature story Feature story | 25 July 2019 Hepatitis C Ukraine Generic medicines prove to be an affordable option in combating Ukraine’s hepatitis C epidemic 4 min Photograph by Simon Ming Press release Press release | 25 July 2019 Hepatitis C Cambodia Cambodia: Simpler and more affordable treatment for hepatitis C saves lives 4 min Oksana Parafeniuk Feature story Feature story Hepatitis C HIV/AIDS Research and development Tuberculosis Vaccines Then & Now in Access to Medicines: Changes & Challenges 4 min Load More
Letter | 09 August 2021 Hepatitis C Open letter to AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C
Photograph by Aleksandr Glyadyelov Feature story Feature story | 25 July 2019 Hepatitis C Ukraine Generic medicines prove to be an affordable option in combating Ukraine’s hepatitis C epidemic 4 min
Photograph by Simon Ming Press release Press release | 25 July 2019 Hepatitis C Cambodia Cambodia: Simpler and more affordable treatment for hepatitis C saves lives 4 min
Oksana Parafeniuk Feature story Feature story Hepatitis C HIV/AIDS Research and development Tuberculosis Vaccines Then & Now in Access to Medicines: Changes & Challenges 4 min
